SQZ Biotech is Drug Delivery in United States that focus on SQZ Biotechnologies Co business. Founded in 2013. They cover business area such as SQZ Biotechnologies Co, transformative cell therapy, patient, cancer, infectious disease, its proprietary technology, multiple material, potential therapeutic, well-tolerate cell therapy, therapeutic benefit, exist cell therapy approach, accelerated production timeline, lengthy hospital stay.
2013
( 11 years old in 2024 )
SQZ Biotechnologies Co
-
200 Arsenal Yards Boulevard
Suite 210
Watertown, MA 02472
United States
Private
SQZ Biotechnologies Cotransformative cell therapypatientcancerinfectious diseaseits proprietary technologymultiple materialpotential therapeuticwell-tolerate cell therapytherapeutic benefitexist cell therapy approachaccelerated production timelinelengthy hospital stay
* We use standard office opening hours in near SQZ Biotech's location as default value for unknown and outdated data. For more valid info, please verify the info from more trusted sources like GoogleMyBusiness, Yelp, FourSquare or similar services.
SQZ Biotech is Drug Delivery business from United States that founded in 2013 (11 years old in 2024), SQZ Biotech business is focusing on SQZ Biotechnologies Co.
SQZ Biotech headquarter office and corporate office address is located in 200 Arsenal Yards Boulevard Suite 210 Watertown, MA 02472 United States.
SQZ Biotech was founded in United States.
In 2024, SQZ Biotech is currently focus on SQZ Biotechnologies Co sector.
Above is snippet of Google Trends for "SQZ Biotechnologies Co" term, if you have problem loading the snippet, please visit here: Google Trend.
Disclaimer: This website is not affiliated with SQZ Biotech, any government agency, does not create this data, vouch for its accuracy, or guarantee that it is the most recent data available. The data displayed is available through open government websites and public online directory. This website expressly disclaims the accuracy, adequacy, or completeness of any data and shall not be liable for any errors, omissions or other defects in, delays or interruptions in such data, or for any actions taken in reliance thereon.